Windtree Therapeutics Inc

NASDAQ: WINT    
Share price (5/13/24): $3.93    
Market cap (5/13/24): $36.1 million
Search in Documents
Key Exhibits
External Links

Plans of Reorganization, Merger, Acquisition or Similar Filter

EX-2.1
from 8-K 48 pages Asset Purchase Agreement Between Varian Biopharmaceuticals, Inc. and Windtree Therapeutics, Inc. Dated April 2, 2024
12/34/56
EX-2.4
from 8-A12G ~50 pages Rights Agreement, Dated as of February 6, 2004
12/34/56
EX-2.2
from 8-A12G ~10 pages Certificate of Designations
12/34/56
EX-2.1
from SC 13G/A 1 page Statement of Control Person
12/34/56
EX-2.1
from SC 13G/A 1 page Statement of Control Person
12/34/56
EX-2
from 8-K ~10 pages Discovery Laboratories Reports 2002 Year End Financial Results Manufacturing of Surfaxin® for Ards Trial to Recommence in March 2003
12/34/56
EX-2.1
from SC 13G/A 1 page Exh. 2.1 to Sch. 13g/a for Discovery Lab
12/34/56
EX-2.1
from SC 13G/A 1 page Exh. 2.1 to Sch. 13g/a for Discovery Lab
12/34/56
EX-2.1
from SC 13G/A 1 page Exh. 2.1 to Sch. 13g/a for Discovery Lab
12/34/56
EX-2.1
from SC 13G/A 1 page Statement of Control Person
12/34/56
EX-2.1
from SC 13G/A 1 page Statement of Control Person
12/34/56
EX-2.1
from SC 13G/A 1 page Statement of Control Person
12/34/56
EX-2.1
from SC 13G/A 1 page Statement of Control Person
12/34/56
EX-2
from 8-K 1 page Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2
from 8-K ~50 pages Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.1
from 10KSB >50 pages Agreement and Plan of Merger
12/34/56
EX-2.1
from 10KSB >50 pages Agreement and Plan of Merger
12/34/56
EX-2.3
from 8-K 1 page Plan of reorganization, merger, acquisition or similar
12/34/56
EX-2.2
from 8-K ~10 pages Form of Registration Rights Agreement
12/34/56
EX-2.1
from 8-K ~50 pages Agreement and Plan of Merger
12/34/56